Evaluation of the Links Between Sleep Disorders and the Risk of Suicide Attempt (HYPNOS)

September 10, 2020 updated by: University Hospital, Lille

Several studies have demonstrated an association between sleep disorders such as insomnia and nightmares to suicidal ideations and behaviors.

Nevertheless, some of these studies are methodologically questionable especially in the exploration of sleep disorders. Furthermore, confounding factors such as depressive symptomatology are not controlled and the measurement of suicidal behavior has often been taken into account as a historical measure, not as a current event, which introduces uncertainties and a lack of precision regarding the temporality of the phenomena.

Today, while the links between sleep disorders and suicidal risk are well known, we have a lack of information on the importance and the role of sleep disorders as a precipitating factor. Indeed, few studies have evaluated the temporal link between sleep disorders and suicidal acts.

The objective of this study is to evaluate the links between acute and chronic sleep disorders and the risk of suicide attempt

Study Overview

Status

Unknown

Conditions

Detailed Description

Pilot, prospective, monocentric case-control study.

There are 2 groups of subjects :

  • group of patients who have made a suicide attempt
  • control group with only suicidal ideas

First visit V1 is performed within the first 72 hours of hospitalization. A re-assessment is scheduled 1 month after (V2).

At V1, collected parameters are : chronic sleep disorders, chronotype, specific sleep disorders in posttraumatic stress disorder, nightmares and the distress associated, childhood trauma, cognitive dysfunction, suicidal ideation and psychopathologic assessment.

At V2, we assess evolution of sleep disturbances and suicidal ideation.

Study Type

Observational

Enrollment (Anticipated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Lille, France
        • Recruiting
        • Hôpital Fontan, CHU

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The population in the study is a population of adults having realized a suicide attempt and without histories of suicide attempt. She(it) will be compared with a population of adults having suicidal ideas without suicidal acting out and without histories of suicide attempt.

Description

Inclusion Criteria

Criterion specific to the studying group :

- Subjects hospitalized and whose indication of hospitalization is a suicide attempt by voluntary drug intoxication or phlebotomy during the last 72 hours, without any history of attempted suicide

Criterion specific to the control group:

- Subjects hospitalized since less than 72 hours, and whose indication of hospitalization is the presence of suicidal ideas, without any history of attempted suicide

Exclusion Criteria:

  • Pregnant of lactating women
  • Diagnosed dementia pathology
  • Proven intellectual disability
  • Patient whose physical or mental state does not allow the passing of the tests of the study
  • Under protective measures (guardianship/supervision)
  • Refusal to participate in the study
  • Diagnosed with chronic or severe psychiatric illness (psychotic disorder, bipolarity)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
case group : realized a suicide attempt
adults having realized a suicide attempt and without histories of suicide attempt.
control group : only suicidal ideas
adults having suicidal ideas without suicidal acting out and without histories of suicide attempt.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sleep disorders intensity by the Insomnia Severity Index (ISI)
Time Frame: at the 48 hours after the hospitalization; at the maximum within 72 hours.
ISI score in the last 2 weeks between a group of suicide attempts and a group with suicidal thoughts suicidal The Insomnia Severity Index has seven questions. The seven answers are added up to get a total score.
at the 48 hours after the hospitalization; at the maximum within 72 hours.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation between Beck Suicide Intent Scale (BSIS) score and ISI score
Time Frame: Baseline (visit inclusion) and at one month ago
Correlation between Beck Suicide Intent Scale (BSIS) score and ISI score The Suicide Intent Scale (SIS) wconsists of 15 questions which are scaled from 0-2, which take into account both the logistics of the suicide attempt as well as the intent. The scale has high reliability and validity. Completed suicides ranked higher in the severity of the logistics than attempted suicides (it was impossible to measure intent for the completed suicides), and those with multiple attempts had higher scores than those who only attempted suicide once
Baseline (visit inclusion) and at one month ago
Evolution of ISI score
Time Frame: At one month +/- 15 days ant at 3 months +/-3 weeks
Assess the evolution of sleep disturbances for each group by ISI Score
At one month +/- 15 days ant at 3 months +/-3 weeks
Chronotype classification by MCTQ
Time Frame: at the 48 hours after the hospitalization; at the maximum within 72 hours;at 3 months +/-3 weeks
Exploratory descriptive measures in the 2 groups
at the 48 hours after the hospitalization; at the maximum within 72 hours;at 3 months +/-3 weeks
Pittsburg Sleep Quality Index (PSQI) score
Time Frame: at the 48 hours after the hospitalization; at the maximum within 72 hours,at 3 months +/-3 weeks
PSQI score between the groups PSQI is a self-report questionnaire that assesses sleep quality over a 1-month time interval. The measure consists of 19 individual items, creating 7 components that produce one global score, and takes 5-10 minutes to complete.
at the 48 hours after the hospitalization; at the maximum within 72 hours,at 3 months +/-3 weeks
Childhood Trauma Questionnaire (CTQ) score
Time Frame: at the 48 hours after the hospitalization; at the maximum within 72 hours.
CTQ score between the groups The Childhood Trauma Questionnaire was developed as a screening tool for histories of abut and neglect. The self-report includes a 28-item test that measures 5 types of maltreatment - emotional, physical, and sexual abuse, and emotional and physical neglect.
at the 48 hours after the hospitalization; at the maximum within 72 hours.
Montréal Cognitive Assessment (MocA)
Time Frame: at the 48 hours after the hospitalization; at the maximum within 72 hours.
cognitive assessment by Moca test
at the 48 hours after the hospitalization; at the maximum within 72 hours.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 4, 2019

Primary Completion (ANTICIPATED)

December 1, 2022

Study Completion (ANTICIPATED)

December 1, 2022

Study Registration Dates

First Submitted

October 16, 2018

First Submitted That Met QC Criteria

January 3, 2019

First Posted (ACTUAL)

January 4, 2019

Study Record Updates

Last Update Posted (ACTUAL)

September 11, 2020

Last Update Submitted That Met QC Criteria

September 10, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Attempted Suicide

3
Subscribe